![Exogenous interleukin-2 can rescue
<i>in-vitro</i>
T cell activation and proliferation in patients with a novel
<i>CARMIL2</i>
mutation]()
Exogenous interleukin-2 can rescue
<i>in-vitro</i>
T cell activation and proliferation in patients with a novel
<i>CARMIL2</i>
mutationShamriz, Oded; Simon, Amos J.; Lev, Atar; Megged, Orli; Ledder, Oren; Picard, Elie; Joseph, Leon; Molho Pessach, Vered; Tal, Yuval; Millman, Peri; Slae, Mordechai; Somech, Raz; Toker, Ori; Berger, Michael · Clinical & Experimental Immunology · 2020